Andrographolide Targets SDHA to Boost Cancer Drug Sensitivity
A new study identifies andrographolide as a compound that disrupts SDHA–SDHAF4 assembly to promote ferroptosis and enhance doxorubicin sensitivity in ...
A new study identifies andrographolide as a compound that disrupts SDHA–SDHAF4 assembly to promote ferroptosis and enhance doxorubicin sensitivity in ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.